A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
PHASE1
This is a study consisting of four cohorts in this setting. In Cohort 1, th...
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
PHASE1
The purpose of this study is to learn about the safety and effects of the s...
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
PHASE1
This is a first-in-human, Phase 1/2, open-label, dose escalation and dose e...
Status
Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
PHASE1
The purpose of this study is to learn about the safety and effects of the s...
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
PHASE1
This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine ...